elonva
n.v. organon - korifolitropín alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - pohlavné hormóny a modulátory z genitálny systém, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).
livmarli
mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.
voncento
csl behring gmbh - Ľudský koagulačný faktor viii, ľudské von willebrand faktor - hemophilia a; von willebrand diseases - blood coagulation factors, von willebrand factor and coagulation factor viii in combination, antihemorrhagics - von willebrand ochorenia (vwd)profylaxii a liečbe krvácania alebo chirurgického krvácania u pacientov s vwd, keď desmopressin (ddavp) liečbou je neúčinné, alebo kontraindikovaný. haemophilia a (vrodený faktor viii nedostatok)profylaxii a liečbe krvácania u pacientov s haemophilia a.
vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidémia - Činidlá modifikujúce lipidy - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
xenpozyme
sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - iné alimentárny trakt a metabolizmus výrobky, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.
tepmetko
merck europe b.v. - tepotinib hydrochloride monohydrate - karcinóm, pľúc bez malých buniek - antineoplastické činidlá - tepmetko as monotherapy is indicated for the treatment of adult patients with advanced non-small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal-epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum-based chemotherapy.
fungitraxx
avimedical b.v. - itraconazole - antimycotics na systémové použitie, triazole deriváty, itraconazole - vtáčie - na liečbu aspergillosis a kandidózy v spoločník vtákov,.
kanuma
alexion europe sas - sebelipáza alfa - lipidový metabolizmus, vrodené chyby - iné alimentárny trakt a metabolizmus výrobky, - kanuma je indikovaný na dlhodobú enzýmovú substitučnú liečbu (ert) u pacientov všetkých vekových skupín s nedostatkom lysozomálnej kyseliny lipázy (lal).
kyprolis
amgen europe b.v. - carfilzomib - viacnásobný myelóm - antineoplastické činidlá - kyprolis in combination with daratumumab and dexamethasone, with lenalidomide and dexamethasone, or with dexamethasone alone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.
replagal
takeda pharmaceuticals international ag ireland branch - agalsidáza alfa - fabryho choroba - iné alimentárny trakt a metabolizmus výrobky, - replagal je indikovaný pre dlhodobú enzým-substitučnú liečbu u pacientov s potvrdenou diagnózou fabryho choroby (deficit α-galaktozidázy a).